Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21395567rdf:typepubmed:Citationlld:pubmed
pubmed-article:21395567lifeskim:mentionsumls-concept:C0085637lld:lifeskim
pubmed-article:21395567lifeskim:mentionsumls-concept:C0064636lld:lifeskim
pubmed-article:21395567lifeskim:mentionsumls-concept:C0175668lld:lifeskim
pubmed-article:21395567pubmed:issue3lld:pubmed
pubmed-article:21395567pubmed:dateCreated2011-3-14lld:pubmed
pubmed-article:21395567pubmed:abstractTextWe report four patients with no preexisting movement disorders who developed oculogyric crises secondary to lamotrigine toxicity and had resolution of these crises after dose reduction. Episode numbers ranged from 1-20 per day and episode duration from 2 s to several hours. Mean plasma concentration of lamotrigine at the time of oculogyric crisis was 15.5 ?g/mL, with a mean dose of 16 mg/kg per day.lld:pubmed
pubmed-article:21395567pubmed:languageenglld:pubmed
pubmed-article:21395567pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21395567pubmed:citationSubsetIMlld:pubmed
pubmed-article:21395567pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21395567pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21395567pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21395567pubmed:statusMEDLINElld:pubmed
pubmed-article:21395567pubmed:monthMarlld:pubmed
pubmed-article:21395567pubmed:issn1528-1167lld:pubmed
pubmed-article:21395567pubmed:authorpubmed-author:BakerJohnJlld:pubmed
pubmed-article:21395567pubmed:authorpubmed-author:MikatiMohamad...lld:pubmed
pubmed-article:21395567pubmed:authorpubmed-author:GallentineWil...lld:pubmed
pubmed-article:21395567pubmed:authorpubmed-author:Veerapandiyan...lld:pubmed
pubmed-article:21395567pubmed:authorpubmed-author:WinchesterSar...lld:pubmed
pubmed-article:21395567pubmed:authorpubmed-author:KansagraSujay...lld:pubmed
pubmed-article:21395567pubmed:copyrightInfoWiley Periodicals, Inc. © 2011 International League Against Epilepsy.lld:pubmed
pubmed-article:21395567pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21395567pubmed:volume52lld:pubmed
pubmed-article:21395567pubmed:ownerNLMlld:pubmed
pubmed-article:21395567pubmed:authorsCompleteYlld:pubmed
pubmed-article:21395567pubmed:paginatione4-6lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:meshHeadingpubmed-meshheading:21395567...lld:pubmed
pubmed-article:21395567pubmed:year2011lld:pubmed
pubmed-article:21395567pubmed:articleTitleOculogyric crises secondary to lamotrigine overdosage.lld:pubmed
pubmed-article:21395567pubmed:affiliationDivision of Pediatric Neurology, Duke University Medical Center, Durham, North Carolina 27710, USA.lld:pubmed
pubmed-article:21395567pubmed:publicationTypeJournal Articlelld:pubmed